Endothelial derived vasoactive factors and leukocyte derived inflammatory mediators in subjects with asymptomatic atherosclerosis

被引:18
作者
Anwaar, I [1 ]
Gottsäter, A
Hedblad, B
Palmqvist, B
Mattiasson, I
Lindgärde, F
机构
[1] Univ Lund Hosp, Dept Med, Wallenberg Lab, S-20502 Malmo, Sweden
[2] Univ Lund Hosp, Dept Vasc & Renal Dis, S-20502 Malmo, Sweden
关键词
D O I
10.1177/000331979804901201
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To clarify relationships between the (endothelial vasodilatory and vasoconstrictive function) and leukocyte inflammatory mediators in subjects with asymptomatic atherosclerosis, we measured (intraplatelet cyclic 3-5C guanosine monophosphate [cGMP] and cyclic 3-5C adenosine monophosphate [cAMP]), plasma endothelin (ET-1), and plasma neopterin in 197 subjects with asymptomatic atherosclerosis (median age 63 years, range 49-69 years). We measured neutrophil protease 4 (NP4), tumor necrosis factor (TNF mu), soluble tumor necrosis factor receptor-1 (sTNFR-1), and neutrophil gelatinase associated lipocalin (NGAL) in 152 of the 197 subjects. Intraplatelet cGMP correlated inversely with plasma ET-1 (r=-0.22; p=0.01), which confirms earlier in vitro data of the inhibitory effect of ET-1 on NO production and/or the cGMP mediated inhibitory effect of NO on ET-1 production. Plasma neopterin as well as NP4 correlated directly with intraplatelet cGMP (r=0.24; p<0.01 and r=0.33; p<0.001, respectively). Intraplatelet cAMP correlated directly with plasma TNF mu (r=0.17; p<0.05) and sTNFR-1 (r=0.20; p<0.05). The relationship between leukocyte derived inflammatory mediators and intraplatelet cyclic nucleotides suggest an antiaggregating effect of leukocytes upon platelets, which may constitute a negative feedback mechanism that inhibits platelet activation during the atherosclerotic inflammatofy process.
引用
收藏
页码:957 / 966
页数:10
相关论文
共 61 条
[1]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]   THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].
ANDERSON, TJ ;
MEREDITH, IT ;
YEUNG, AC ;
FREI, B ;
SELWYN, AP ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493
[3]  
Anwaar I, 1996, INT ANGIOL, V15, P201
[4]   STUDIES OF THE RELEASE AND TURNOVER OF A HUMAN NEUTROPHIL LIPOCALIN [J].
AXELSSON, L ;
BERGENFELDT, M ;
OHLSSON, K .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (07) :577-588
[5]  
BATTISTINI B, 1993, LAB INVEST, V68, P600
[6]  
Belch Jill J. F., 1994, Current Opinion in Lipidology, V5, P440, DOI 10.1097/00041433-199412000-00007
[7]   DESIGN AND FEASIBILITY [J].
BERGLUND, G ;
ELMSTAHL, S ;
JANZON, L ;
LARSSON, SA .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (01) :45-51
[8]   RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
BOULANGER, C ;
LUSCHER, TF .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :587-590
[9]  
BROOKER G, 1979, ADV CYCLIC NUCLEOTID, P1
[10]   EVIDENCE FOR ALTERED PLATELET NITRIC-OXIDE SYNTHESIS IN ESSENTIAL-HYPERTENSION [J].
CADWGAN, TM ;
BENJAMIN, N .
JOURNAL OF HYPERTENSION, 1993, 11 (04) :417-420